Antibody molecules to C5AR1 and uses thereof
US12187807B2 · kind B2 · utility
0Cited by
48References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 18, 2023 |
| Grant date | Jan 7, 2025 |
| Priority date | — |
| Expiry date | Aug 18, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibody molecules that specifically bind to C5aR1 are disclosed. The antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as ANCA-vasculitis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.